Protifarm
Series B in 2019
Protifarm operates a state-of-the-art vertical farm in the Netherlands, producing innovative and sustainable ingredients derived from insects. Its product range includes protein powder, isolates, oils, chitin powder, fertilizers, and other bio-based products, catering to food, personal care, and pharmaceutical industries.
NutriLeads
Series A in 2017
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Stroke2prevent
Series B in 2016
Stroke2prevent B.V. is a medical device company focused on developing innovative solutions to improve patient outcomes in cardiology. The company’s flagship product, A-View, addresses the challenges associated with Transoesophageal Echocardiography (TEE) by eliminating the 'blind-spot' caused by the trachea. A-View provides comprehensive imaging of the thoracic aortic arch, facilitating the detection of atherosclerosis and the diagnosis of aortic diseases. Additionally, the device aids in monitoring vascular flow, thereby supporting physicians in making informed decisions for optimal patient care. Stroke2prevent also develops a balloon catheter device designed to enhance heart surgery outcomes by determining the correct operational strategy for patients with heart conditions, ultimately contributing to their recovery and improving results in both cardiology and interventional procedures.
Solease
Venture Round in 2016
Solease facilitates access to solar energy by offering solar panel rentals. Customers pay a monthly fee lower than their current electricity bills, with Solease handling purchase, financing, installation, repair, insurance, and monitoring. This enables immediate savings on energy costs and reduces carbon footprint.
iWelcome is a European-based provider of Identity as-a-Service, specializing in identity and access management solutions for both consumers and workforce processes. The company serves a diverse range of industries, including banking, insurance, utilities, media, travel, retail, and government sectors, with millions of consumers and hundreds of thousands of employees relying on its services daily. iWelcome's platform offers a comprehensive view of user identities, facilitating seamless, privacy-protected interactions across multiple channels while enhancing user registration and conversion rates. Recognized by industry analysts as a leader in product innovation, iWelcome leverages best-of-breed private cloud technology to deliver efficient services without compromising critical resources, thereby ensuring a low total cost of ownership and rapid deployment times.
NutriLeads
Seed Round in 2015
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Vector Fabrics
Series C in 2015
Vector Fabrics is a technology company that specializes in developing programming tools designed to optimize software for multicore hardware platforms. As the industry shifts toward multicore architectures, with processors featuring two to hundreds of cores, the company's solutions address the challenges software vendors face in enhancing performance while managing power consumption. Many applications currently fail to leverage the capabilities of multicore systems effectively, often resulting in slower performance and potential errors such as data races. Vector Fabrics' tools provide comprehensive analysis of software behavior, identifying critical bugs and offering predictive profiling capabilities. This insight enables developers to modify their code to fully utilize the advantages of parallel execution, thereby improving the efficiency of applications across various sectors, including mobile, automotive, networking, and industrial markets.
Stroke2prevent
Venture Round in 2014
Stroke2prevent B.V. is a medical device company focused on developing innovative solutions to improve patient outcomes in cardiology. The company’s flagship product, A-View, addresses the challenges associated with Transoesophageal Echocardiography (TEE) by eliminating the 'blind-spot' caused by the trachea. A-View provides comprehensive imaging of the thoracic aortic arch, facilitating the detection of atherosclerosis and the diagnosis of aortic diseases. Additionally, the device aids in monitoring vascular flow, thereby supporting physicians in making informed decisions for optimal patient care. Stroke2prevent also develops a balloon catheter device designed to enhance heart surgery outcomes by determining the correct operational strategy for patients with heart conditions, ultimately contributing to their recovery and improving results in both cardiology and interventional procedures.
Sigmascreening
Private Equity Round in 2014
Sigmascreening B.V. is a medical device company based in Amsterdam, Netherlands, specializing in the development of innovative products for breast cancer screening. Established in 2010 as a spin-off from the Academic Medical Center Amsterdam, Sigmascreening focuses on enhancing digital mammography, the recognized standard for breast cancer detection. One of its notable products is the Sensitive Sigma Paddle, designed to measure the mechanical properties of breast tissue during compression, thereby improving the accuracy and effectiveness of screening processes. The company is committed to advancing technology in the field of breast cancer diagnostics through its ongoing product development efforts.
Informaat
Private Equity Round in 2013
Informaat is a design consultancy that focuses on enhancing digital customer experiences. The company supports organizations in developing and implementing their digital strategies by specializing in user experience (UX) and customer experience (CX) projects. Informaat facilitates collaboration among designers, stakeholders, and customers to create effective digital touchpoints. By streamlining the processes of defining, designing, testing, deploying, and managing these touchpoints across various channels, Informaat aims to elevate customer experience design to a new level, ensuring that enterprises can adapt swiftly to the evolving digital landscape.
SolabCool B.V.
Private Equity Round in 2013
SolabCool B.V. is a Dutch company based in Duiven that specializes in the manufacture of air conditioning systems. These innovative units utilize waste heat to generate cooling, making them an environmentally friendly option for both residential and commercial spaces. By leveraging waste heat, SolabCool aims to enhance energy efficiency and reduce overall energy consumption in cooling applications.
RingCredible
Series A in 2013
RingCredible aims to disrupt the telecom market in several countries by closing the gap between mobile providers and free peer-2-peer Apps. It offers nearly free international phone calls to all landlines and mobiles worldwide over Wi-Fi, 3G and 4G networks.
It's easy to use with a singple purpose App approach.
This brings some advantages and disadvantages.
Unlike most VoIP apps, RingCredible does not does not upload the contact list to the cloud, does not sell a user’s data, and does not use ads to disrupt the user experience or track online habits. It’s practical in that it seamlessly utilizes a user’s normal mobile contact list and lets them call anyone, anywhere, on any phone. It doesn´t use closed user groups, which means that users can call without the other person needing to download the app, and without having an internet connection. The recipient of the call doesn’t have to know that they are being phoned on a mobile app, as the caller’s regular cell phone number is displayed on the screen.
Perrit is a technology company based in Hengelo, Netherlands, specializing in the development of hosted online software solutions. The company offers a diverse product portfolio that includes cloud-based business applications such as project portfolio management services, customer relationship management tools, and enterprise resource planning software. Perrit's solutions are designed to streamline process automation, deployment, provisioning, and billing, helping users minimize errors associated with manual tasks. By centralizing access to essential files on a single platform, Perrit aims to enhance productivity and efficiency for its clients.
CWR Mobility
Series B in 2011
CWR Mobility is a software vendor specializing in mobile customer relationship management (CRM) solutions. The company develops and markets CWR Mobile CRM, a multi-platform application based on the Microsoft Dynamics platform, designed to enhance the efficiency and effectiveness of field sales, service, and marketing professionals. CWR Mobile CRM provides users with instant access to accurate data and enables real-time communication with back-office teams, whether online or offline. The software integrates seamlessly with existing Dynamics CRM installations, supporting various mobile devices including Windows Phone, iPhone/iPad, BlackBerry, and Android. Its user-friendly interface, rapid deployment, and adaptability to evolving business needs make it a valuable tool for organizations of all sizes. Additionally, CWR Mobility has been recognized as a Microsoft Gold Certified Partner and has earned the Mobility Business-to-Business Application Partner of the Year award twice, highlighting its commitment to delivering high-quality mobile solutions.
Syntarga
Venture Round in 2010
Syntarga is a privately held biopharmaceutical company dedicated to the discovery and development of innovative Antibody-Drug Conjugate (ADC) technology for cancer treatment. The company specializes in creating cell-killing drugs and linker-drug combinations specifically designed for tumor-targeting antibodies and monoclonal antibody derivatives. Syntarga's advanced chemistry capabilities and proprietary Potent Payload Technology enable it to develop unique antibody payload chemistries that, when combined with third-party antibodies, result in next-generation ADC products. By leveraging its expertise and proprietary technologies, Syntarga aims to generate and commercialize a diverse portfolio of ADC solutions, both independently and through partnerships.
Health Impact Solutions
Venture Round in 2009
Health Impact Solutions Nederland BV provides a Web-based program for the personal development of individuals in organizations. Its program focuses on stress related conditions in the workplace. The company is based in Ede, the Netherlands.
iDiDiD
Venture Round in 2009
iDiDiD, pronounced "I Did It", is a social network new style which revolves around your complete online identity and the connection with (un)known events of your personal preference. iDiDiD has been developed in such a way, that you as a user can make your personal preferences and interests known in the field; hobby, music, education, work, sport, travel, entertainment and lifestyle. Because of this it is possible that the system gets to know it's members members. Then iDiDiD wil try you to be of service and provide you with relevant (outgoing) tips and recommendations, where you as a user will probably be interested in. An important aspect is forming your online identity, iDiDiD call this your "iDNA".
Optiqua develops highly sensitive biosensors for real-time monitoring of contaminants and biochemical substances in water. Its patented 'Lab-on-Chip' sensor technology combines integrated optics, biochemistry, microfluidics, and electronics to ensure high-end laboratory sensitivity.
EXENDIS is a worldwide active company, which designs and manufactures energy conversion equipment for applications for the market segments MOBILITY, INFRASTRUCTURE and RENEWABLE ENERGY. Their extensive product line covers the power range from 60VA up to 500kVA.
Pepscan is a biotechnology firm specializing in peptide development and production, leveraging 25 years of expertise in the field. Based in Lelystad, the Netherlands, Pepscan provides an extensive range of services, including peptide synthesis, modifications, high-throughput screening, and the production of R&D- to GMP-grade peptides. The company utilizes patented technologies such as CLIPS, which stabilizes peptides in active conformations, and offers phage display capabilities alongside an epitope mapping service platform. These resources enable biotech companies to develop personalized anti-cancer vaccines targeting tumor-specific antigens. Pepscan's comprehensive approach supports clients throughout the entire peptide lifecycle, from research and development to clinical applications, including libraries and neoantigen vaccines.
Pepscan is a biotechnology firm specializing in peptide development and production, leveraging 25 years of expertise in the field. Based in Lelystad, the Netherlands, Pepscan provides an extensive range of services, including peptide synthesis, modifications, high-throughput screening, and the production of R&D- to GMP-grade peptides. The company utilizes patented technologies such as CLIPS, which stabilizes peptides in active conformations, and offers phage display capabilities alongside an epitope mapping service platform. These resources enable biotech companies to develop personalized anti-cancer vaccines targeting tumor-specific antigens. Pepscan's comprehensive approach supports clients throughout the entire peptide lifecycle, from research and development to clinical applications, including libraries and neoantigen vaccines.